Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paritha I. Arumugam
Observed names:
Arumugam, P,
P. Arumugam,
P.I. Arumugam,
PARITHA I. ARUMUGAM,
Paritha Arumugam,
Paritha I Arumugam
show all 6
Institutions:
Cincinnati Children's Hospital Medical Center,
University of Cincinnati Medical Center
Observed institutions:
Cincinnati Children's Hospital Medical Center,
Children's Hospital Los Angeles,
Saban Research Institute,
University of Cincinnati,
University of Cincinnati Medical Center
ORCID:
0000-0002-3778-6022
Observed ORCID:
0000-0002-3778-6022
OpenAlex ID:
A5015023040
Works
73
Awards
1
Pulmonary macrophage transplantation therapy
2014
·
Takuji Suzuki
, Paritha Arumugam
, et al.
·
Nature
·
324
Improved Human β-globin Expression from Self-inactivating Lentiviral Vectors Carrying the Chicken Hypersensitive Site-4 (cHS4) Insulator Element
2007
·
Paritha I Arumugam
, Jessica Scholes
, et al.
·
Molecular Therapy
·
138
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
2018
·
Cormac McCarthy
, Elinor Lee
, et al.
·
Nature Communications
·
99
PDF
Targeting cholesterol homeostasis in lung diseases
2017
·
Anthony Sallese
, Takuji Suzuki
, et al.
·
Scientific Reports
·
85
PDF
Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia
2020
·
Kristin M. Hudock
, Margaret S. Collins
, et al.
·
American Journal of Physiology-Lung Cellular and Molecular Physiology
·
83
Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region
2009
·
Paritha I Arumugam
, Tomoyasu Higashimoto
, et al.
·
Molecular Therapy
·
83
PDF
Mechanism of Reduction in Titers From Lentivirus Vectors Carrying Large Inserts in the 3′LTR
2009
·
Fabrizia Urbinati
, Paritha Arumugam
, et al.
·
Molecular Therapy
·
75
PDF
The 3′ Region of the Chicken Hypersensitive Site-4 Insulator Has Properties Similar to Its Core and Is Required for Full Insulator Activity
2009
·
Paritha I. Arumugam
, Fabrizia Urbinati
, et al.
·
PLoS ONE
·
69
PDF
Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice
2015
·
Paritha I. Arumugam
, Eric S. Mullins
, et al.
·
Blood
·
66
Perforin Gene Transfer Into Hematopoietic Stem Cells Improves Immune Dysregulation in Murine Models of Perforin Deficiency
2014
·
Marlene Carmo
, Kimberly A Risma
, et al.
·
Molecular Therapy
·
55
Role of GM-CSF in regulating metabolism and mitochondrial functions critical to macrophage proliferation
2021
·
Matthew Wessendarp
, Miki Watanabe-Chailland
, et al.
·
Mitochondrion
·
50
PDF
Thrombin‐PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment
2020
·
Patrick G. Schweickert
, Yi Yang
, et al.
·
Journal of Thrombosis and Haemostasis
·
49
FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation
2020
·
Markaisa Black
, Paritha Arumugam
, et al.
·
Molecular Biology of the Cell
·
49
PDF
Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside
2010
·
Paritha Arumugam
, Punam Malik
·
Hematology
·
49
PDF
Successful Correction of the Human Cooley's Anemia β‐Thalassemia Major Phenotype Using a Lentiviral Vector Flanked by the Chicken Hypersensitive Site 4 Chromatin Insulator
2005
·
PUNAM MALIK
, PARITHA I. ARUMUGAM
, et al.
·
Annals of the New York Academy of Sciences
·
48
RhoA GTPase controls cytokinesis and programmed necrosis of hematopoietic progenitors
2013
·
Xuan Zhou
, Maria Carolina Florian
, et al.
·
The Journal of Experimental Medicine
·
43
PDF
Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra−/− Mice
2019
·
Paritha Arumugam
, Takuji Suzuki
, et al.
·
Molecular Therapy
·
38
PDF
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13
2015
·
Marthe-Sandrine Eiymo Mwa Mpollo
, Eric B. Brandt
, et al.
·
Journal of Clinical Investigation
·
34
PDF
Gene Therapy for β-Thalassemia
2005
·
Punam Malik
, Paritha I. Arumugam
·
Hematology
·
34
PDF
Safety and Efficacy of Aru-1801 in Patients with Sickle Cell Disease: Early Results from the Phase 1/2 Momentum Study of a Modified Gamma Globin Gene Therapy and Reduced Intensity Conditioning
2021
·
Michael Grimley
, Monika Asnani
, et al.
·
Blood
·
28
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial
2025
·
Michael Grimley
, Stella M. Davies
, et al.
·
Nature Medicine
·
26
Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential
2017
·
Michael Aaron Goodman
, Paritha Arumugam
, et al.
·
Journal of Virology
·
25
PDF
Function and Safety of Lentivirus-Mediated Gene Transfer for CSF2RA -Deficiency
2017
·
Miriam Hetzel
, Takuji Suzuki
, et al.
·
Human Gene Therapy Methods
·
22
Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia
2019
·
Md Nasimuzzaman
, Paritha I. Arumugam
, et al.
·
Blood Advances
·
20
PDF
Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies
2014
·
Hans-Peter Kiem
, Paritha I Arumugam
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
20
Show more works
View as search
Works count:
73
Citation count:
1,684
H-index:
22
I10-index:
27
Year
Topic
Type